Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

payer survey

Oxford University Press advertising and custom content team hosts their first ever virtual drop-in sessions

This is your chance to ask Oxford University Press anything: a quick question about advertising deadline dates for the European Heart Journal or a full presentation on the benefits of...

Oxford University Press

An update from Oxford University Press Advertising and Corporate Services

Angela Joines, our advertising and reprints manager in Cary, North Carolina, has recorded a quick message to give you a glimpse of how we’re getting on working remotely in these...

Oxford University Press

- PMLiVE

Moderna posts encouraging early data for personalised cancer vaccine

Vaccine tested alongside Merck's Keytruda

- PMLiVE

Shaping the organisation to enable intelligent, precision engagement

By Simon Grime

- PMLiVE

Pfizer, BioNTech set to price COVID-19 vaccine ‘well below typical market rates’

Chief strategy officer revealed plans at FT virtual event

- PMLiVE

AZ, Amgen’s investigational asthma drug comes good in phase 3

Tezepelumab evaluated in late-stage trial of severe asthma patients

- PMLiVE

Russia claims its COVID-19 vaccine is over 90% effective

Interim results come from first 16,000 participants to receive two doses of the vaccine

- PMLiVE

Sinovac’s late-stage COVID-19 vaccine trial paused in Brazil

Health regulator Anvisa reports that pause is due to severe adverse event

- PMLiVE

Creative med affairs and bridging the healthcare gap

Within the healthcare industry, any patient-facing activity has traditionally been the domain of marketing teams – be that brand marketing or marketing individual products. Recently, however, a trend has emerged...

Page & Page Health

- PMLiVE

NHS asked to ‘ready’ itself to provide Pfizer’s COVID-19 vaccine

Health Secretary Matt Hancock expects widespread roll-out early next year

- PMLiVE

Eli Lilly’s COVID-19 antibody scores FDA emergency use approval

Drug authorised to treat mild-to-moderate COVID-19

How can pharma align its brand strategy with the NHS Reset?

Oli Hudson, of Wilmington Healthcare, explores how pharma should respond to plans to ‘reboot’ the NHS during the covid recovery era

Wilmington Healthcare

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links